MSSCorps
6830High ConvictionMSSCorp
CPO Inspection Monopoly
Current MC
$1.4B
Target
$7.0B
Investment Thesis
MSSCorps holds a functional monopoly over CPO inspection — specifically non-destructive infrared (IR) leakage detection for Co-Packaged Optics yields. The CEO explicitly stated 'the company's goal is to seize a 90 percent share of the CPO inspection market' (translated: 100%, they just can't say antitrust). Customers include TSM, NVDA, AAPL, AMAT, LRCX, ASML, INTC. They've aggressively used litigation (Enli Tech lawsuit) to lock out rivals. At ~$1.2-1.4B MC for what could become a $5-9B monopoly.
Moat
Non-destructive IR CPO inspection monopoly. Hyperscalers can't risk switching suppliers given patent litigation pendency.
"The KLA of CPO inspection — monopoly pricing power at 1/8th the MC"
Catalysts
- CEO target: 90% CPO inspection market share (de facto monopoly)
- Customers: TSM, NVDA, AAPL, AMAT, LRCX, ASML, INTC
- NVDA and hyperscalers won't risk switching while Enli Tech patent dispute ongoing
- CPO volume ramp = proportional inspection revenue — pure leverage play
- Litigation strategy creating durable competitive moat
Risks
- Patent suit (Enli Tech) could go badly — would open door to competition
- Korea-listed — fund mandate barriers for US institutions
- CPO volume ramp timing could be delayed by 6-12 months